Mandate

Vinge advises Aller Media AB and Egmont Holding AB on acquisition of a share of Mediafy AB

June 04, 2013

Vinge is advising Aller Media AB and Egmont Holding AB in connection with their acquisition of a 40 per cent interest in Mediafy AB from Bonnier Tidskrifter AB. Mediafy AB is the ultimate parent company in the Mediafy Group, which includes subsidiaries in Sweden, Finland and Norway. The Mediafy group is the largest distributor of magazine subscriptions in the Nordic countries through its websites Tidningskungen.se, Bladkongen.no and Lehtikuningas.fi. Closing of the transaction is subject to applicable competition law approvals and other customary closing conditions.

The Vinge team advising Aller and Egmont includes partner Henrik Borna, associate Christoffer Thalin. Partner Pär Remnelid and associate Johanna Bergdahl are providing competition law advice.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025